rss
Br J Ophthalmol 2007;91:971-976 doi:10.1136/bjo.2006.110908
  • Laboratory science - Extended reports

Presence and phenotype of dendritic cells in uveal melanoma

  1. Marta E Polak1,
  2. Nicola J Borthwick3,
  3. Penny Johnson1,
  4. John L Hungerford5,
  5. Bernie Higgins6,
  6. Silvana Di Palma4,
  7. Martine J Jager2,
  8. Ian A Cree1
  1. 1Translational Oncology Research Centre, Queen Alexandra Hospital, Portsmouth, UK
  2. 2Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
  3. 3Department of Pathology, Institute of Ophthalmology, London, UK
  4. 4Department of Histopathology, University of Surrey, The RSCH, Guildford, Surrey, UK
  5. 5Department of Pathology, Moorfield Eye Hospital, London, UK
  6. 6SHSSW, University of Portsmouth, Portsmouth, UK
  1. Correspondence to: MrsM E Polak Translational Oncology Research Centre, Queen Alexandra Hospital, Southwick Hill, Portsmouth PO6 3LY, UK; marta.polak{at}porthosp.nhs.uk
  • Accepted 28 February 2007
  • Published Online First 8 March 2007

Abstract

Background: Uveal melanoma arises in an immune-privileged site and can itself add to the immunosuppressive environment. Previous studies on cutaneous melanoma have shown the presence of tolerogenic dendritic cells (DCs), which could play an important role in the progression of the tumour.

Aim: To examine the presence and functional status of DCs in a small series of uveal melanomas.

Methods: 10 cases of uveal melanoma were examined for the expression of FXIIIa, CD68, human leucocyte antigen (HLA)-DR, CD40, CD83, transforming growth factor βR1 and indolamine 2,3 dioxygenase by immunohistochemical analysis on sections embedded in paraffin wax.

Results: CD68-positive macrophages were present in all of the tumours and were evenly distributed throughout. DCs expressing FXIIIa-positive were seen in 7 cases, and were often found concentrated in foci within the tumour mass. These cells were dendritic and expressed high levels of HLA-DR. The DCs did not express the maturation markers CD83 or CD40. In one case, concentration of DCs around the area of tumour necrosis was observed, and some of these cells expressed CD83.

Conclusion: Numerous tolerising antigen-presenting cells may play a role in melanoma-related immunosuppression in the eye, although activation of DCs may be associated with tumour necrosis.

Footnotes

  • Published Online First 7 March 2007

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. bjo.2006.110908v1
    2. 91/7/971 most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.